Angiotensin receptor blockers – olmesartan

Last updated on October 6, 2022

Special Authority requests can now be submitted online. It's simple and quick!

Generic Name		olmesartan, including in combination with hydrochlorothiazide
Form		20 mg, 40 mg, 20 mg/12.5 mg, 40 mg/12.5 mg, 40 mg/25 mg
Form		tablet

Criteria	Approval Period
1. Person identified as experiencing intractable cough or angioedema on an angiotensin converting enzyme inhibitor (ACE-I). AND 2. Failure on optimal doses of, or intolerance to, ALL reference drugs: candesartan, losartan, telmisartan AND valsartan.	Indefinite

Criteria

Approval Period

1. Person identified as experiencing intractable cough or angioedema on an angiotensin converting enzyme inhibitor (ACE-I).

AND

2. Failure on optimal doses of, or intolerance to, ALL reference drugs: candesartan, losartan, telmisartan AND valsartan.

Indefinite

Practitioner exemptions

No practitioner exemptions.

Special notes

Individuals requiring a diuretic combination product must satisfy the same criteria.

Special Authority requests

Log in to eForms
HLTH 5492: ARB Request Form

Did you find what you were looking for?

The B.C. Public Service acknowledges the territories of First Nations around B.C. and is grateful to carry out our work on these lands. We acknowledge the rights, interests, priorities, and concerns of all Indigenous Peoples - First Nations, Métis, and Inuit - respecting and acknowledging their distinct cultures, histories, rights, laws, and governments.

More topics

Angiotensin receptor blockers – olmesartan

Practitioner exemptions

Special notes

Special Authority requests